Gensupen 2®

1. Product Overview

GensuPen 2 is an automatic, multi-use insulin injection pen — meaning it is not a medication but a medical device that supports insulin injection. GensuPen 2 is designed for diabetes patients — so that they (or caregivers) can inject insulin easily, accurately, and safely. According to information from SciGen, GensuPen 2 is classified as a “Medical Device” and is supplied in “emerging markets.”

GensuPen 2 is typically used with insulin from the Gensulin/SciLin line — also distributed by SciGen — which ensures compatibility between the pen and the insulin cartridge.

2. Function and Use

• GensuPen 2 allows patients to inject insulin at the dose prescribed by their doctor with high precision — the dose can be adjusted from 1 to 60 insulin units, with a dose increment of 1 unit.

• The device simplifies the insulin injection process: users do not need to draw and measure the dose manually with a syringe — just “attach” the appropriate insulin cartridge + needle, select the dose on the pen, then inject. This is particularly useful for diabetic patients managing insulin at home.

• The pen features an automatic injection system with a stable mechanism, ensuring insulin is injected steadily, conveniently, and reducing dose confusion — contributing to fewer injection errors.

3. Design, Technical Features & Compatibility

• GensuPen 2 is a multi-use injection pen (not a single-use pen) — meaning after each use, the user needs to discard the single-use needle but can keep the pen body for continued use.

• The pen is compatible with standard 3.0 ml (300 unit) insulin cartridges — typically insulin cartridges from the Gensulin/SciLin line.

• It can be used with single-use needles of various lengths — for example, 4 mm, 5 mm, 6 mm, 8 mm — according to relevant ISO standards.

• When selecting the dose: the pen allows precise adjustment by individual units, with a safe mechanism, ensuring the dose is measured correctly → suitable for those requiring accurate doses (such as injecting insulin multiple times a day, or using small doses).

• The pen has a smooth injection mechanism, is easy to operate, and provides “feedback” (which could be sound or signal) upon completion of injection — helping users know that the insulin has been delivered, preventing underdosing.

4. Advantages & Benefits

• With GensuPen 2, diabetes patients can self-inject insulin at home more easily, reducing dependence on medical facilities/clinics — improving quality of life and convenience in disease management.

• Injection with the pen helps ensure accurate, stable doses, reducing errors compared to manual syringe injection — this is crucial in diabetes treatment, where insulin doses must be correct — to prevent hypoglycemia or hyperglycemia.

• Compatibility with standard insulin cartridges and single-use needles makes the pen flexible to use — advantageous if insulin/accessory products are easily found in many markets (especially emerging markets).

• The multi-use pen is more economical than single-use (disposable) pens, reducing costs if users need long-term insulin injections.

5. Limitations, Notes & Conditions of Use

• GensuPen 2 is a device — not insulin — so you still need a suitable insulin cartridge to use it. If the insulin cartridge is not the correct standard (3 ml, compatible with the pen), the pen cannot be used.

• The pen is only suitable for single-use needles of the correct size (according to specified standards). Reuse of needles is not recommended, as it can cause infection.

• As it is a multi-use pen, users need to pay attention to proper storage, hygiene, and changing the needle for each injection, to avoid infection or device damage.

• The pen is for single-person use only — do not share with others, to avoid hygiene risks and cross-contamination. +1

• Since the pen only supports insulin injection, insulin dosage & treatment regimen must still be prescribed by a doctor — the pen does not determine the dose or replace medical advice.

6. Role & Significance in SciGen's Portfolio

Within SciGen's product system, GensuPen 2 plays the role of an “insulin injection support device” — complementing insulin products such as Gensulin/SciLin. Providing GensuPen 2 helps complete the diabetes treatment chain: from insulin, injection device → to the patient. This aligns with SciGen's orientation: not only providing medication but also comprehensive medical devices/solutions for easier patient access and convenient treatment — especially in emerging markets.